News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
668,720 Results
Type
Article (54264)
Company Profile (279)
Press Release (614162)
Multimedia
Podcasts (124)
Webinars (20)
Section
Business (175885)
Career Advice (2590)
Deals (32186)
Drug Delivery (145)
Drug Development (78341)
Employer Resources (148)
FDA (17001)
Job Trends (14016)
News (311815)
Policy (31839)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2798)
Academic (1)
Accelerated approval (58)
ADA (42)
Adcomms (38)
Allergies (194)
Alliances (47385)
ALS (226)
Alzheimer's disease (1850)
Antibody-drug conjugate (ADC) (504)
Approvals (17422)
Artificial intelligence (748)
ASCO (318)
Autoimmune disease (341)
Automation (62)
Bankruptcy (348)
Best Places to Work (11174)
BIO (62)
BIOSECURE Act (23)
Biosimilars (228)
Biotechnology (187)
Bladder cancer (198)
Brain cancer (80)
Breast cancer (797)
Cancer (6279)
Cardiovascular disease (518)
Career advice (2203)
Career pathing (44)
CAR-T (362)
CDC (66)
Celiac Disease (3)
Cell therapy (992)
Cervical cancer (51)
Clinical research (68710)
Collaboration (2221)
Commercialization (1)
Company closure (6)
Compensation (1034)
Complete response letters (99)
COVID-19 (2736)
CRISPR (118)
C-suite (1238)
Cystic fibrosis (163)
Data (8467)
Decentralized trials (2)
Denatured (41)
Depression (184)
Dermatology (94)
Diabetes (664)
Diagnostics (6662)
Digital health (57)
Diversity (12)
Diversity, equity & inclusion (36)
Drug discovery (380)
Drug pricing (213)
Drug shortages (33)
Duchenne muscular dystrophy (305)
Earnings (71152)
Editorial (75)
Employer branding (18)
Employer resources (136)
Events (95386)
Executive appointments (1127)
FDA (21046)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1843)
Gene editing (254)
Generative AI (66)
Gene therapy (791)
GLP-1 (1132)
Government (4489)
Grass and pollen (7)
Guidances (415)
Healthcare (18314)
Hematology (186)
HIV (90)
Huntington's disease (57)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (107)
Immunology and inflammation (289)
Immuno-oncology (111)
Indications (214)
Infectious disease (3109)
Inflammatory bowel disease (232)
Inflation Reduction Act (11)
Influenza (139)
Intellectual property (318)
Interviews (491)
IPO (15097)
IRA (51)
Job creations (3200)
Job search strategy (1786)
JPM (66)
Kidney cancer (21)
Labor market (91)
Layoffs (527)
Leadership (46)
Legal (7229)
Liver cancer (106)
Longevity (29)
Lung cancer (819)
Lymphoma (462)
Machine learning (67)
Management (50)
Manufacturing (1112)
Marketing (2)
MASH (214)
Medical affairs (1)
Medical device (12610)
Medtech (12759)
Mergers & acquisitions (18337)
Metabolic disorders (1655)
mRNA (236)
Multiple sclerosis (208)
NASH (22)
Neurodegenerative disease (473)
Neuropsychiatric disorders (111)
Neuroscience (3506)
Neurotech (1)
NextGen: Class of 2026 (6222)
Non-profit (4641)
Now hiring (56)
Obesity (758)
Opinion (333)
Ovarian cancer (233)
Pain (274)
Pancreatic cancer (355)
Parkinson's disease (402)
Partnered (37)
Patents (633)
Patient recruitment (763)
Peanut (65)
People (54940)
Pharmaceutical (60)
Pharmacy benefit managers (31)
Phase 1 (21286)
Phase 2 (30132)
Phase 3 (22777)
Pipeline (9663)
Policy (348)
Postmarket research (2482)
Preclinical (9105)
Press Release (56)
Prostate cancer (336)
Psychedelics (61)
Radiopharmaceuticals (346)
Rare diseases (1212)
Real estate (5149)
Recruiting (69)
Regulatory (26024)
Reports (37)
Research institute (2612)
Resumes & cover letters (425)
Rett syndrome (43)
RNA editing (28)
RSV (88)
Schizophrenia (179)
Series A (313)
Series B (229)
Service/supplier (5)
Sickle cell disease (117)
Special edition (26)
Spinal muscular atrophy (178)
Sponsored (48)
Startups (3390)
State (2)
Stomach cancer (17)
Supply chain (128)
Tariffs (84)
The Weekly (80)
Vaccines (1152)
Venture capital (125)
Weight loss (497)
Women's health (135)
Worklife (19)
Date
Today (92)
Last 7 days (466)
Last 30 days (2569)
Last 365 days (29493)
2026 (15405)
2025 (29279)
2024 (33583)
2023 (37753)
2022 (48293)
2021 (52376)
2020 (50945)
2019 (44286)
2018 (33598)
2017 (30769)
2016 (29620)
2015 (34245)
2014 (26913)
2013 (23122)
2012 (24535)
2011 (25100)
2010 (23347)
Location
Africa (858)
Alabama (92)
Alaska (7)
Arizona (294)
Arkansas (15)
Asia (40848)
Australia (6913)
California (13006)
Canada (3788)
China (1481)
Colorado (565)
Connecticut (560)
Delaware (428)
Europe (90956)
Florida (2007)
Georgia (410)
Hawaii (3)
Idaho (54)
Illinois (1100)
India (95)
Indiana (616)
Iowa (22)
Japan (580)
Kansas (130)
Kentucky (44)
Louisiana (51)
Maine (88)
Maryland (1536)
Massachusetts (9326)
Michigan (357)
Minnesota (630)
Mississippi (6)
Missouri (151)
Montana (35)
Nebraska (29)
Nevada (143)
New Hampshire (82)
New Jersey (3554)
New Mexico (30)
New York (3523)
North Carolina (1678)
North Dakota (10)
Northern California (6450)
Ohio (389)
Oklahoma (24)
Oregon (44)
Pennsylvania (2598)
Puerto Rico (32)
Rhode Island (43)
South America (1144)
South Carolina (84)
South Dakota (1)
Southern California (5194)
Tennessee (214)
Texas (2165)
United States (46320)
Utah (403)
Vermont (2)
Virginia (351)
Washington D.C. (78)
Washington State (1075)
West Virginia (3)
Wisconsin (130)
Wyoming (2)
668,720 Results for "california institute for regenerative medicine cirm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immusoft Awarded $15 Million in Funding from the California Institute for Regenerative Medicine
March 30, 2026
·
4 min read
Press Releases
Kenai Therapeutics Receives $8M Grant from California Institute for Regenerative Medicine (CIRM) to Advance RNDP-001 for Treatment of Idiopathic Parkinson’s Disease
January 5, 2026
·
4 min read
Biotech Beach
Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM) - April 30, 2024
Lineage Cell Therapeutics, Inc. today announced that the Company has received an Education Conference II Grant from the California Institute for Regenerative Medicine (CIRM).
April 30, 2024
·
9 min read
Press Releases
Scribe Therapeutics Awarded More Than $25 Million From CIRM to Accelerate Additional CRISPR-Based Gene Editing Therapies for Cardiometabolic Disease Into Clinical Trials
June 19, 2026
·
8 min read
Biotech Beach
Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)
Aspen Neuroscience, Inc. has received a CLIN2 grant award of $8 million from the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, to support clinical research aimed at treating Parkinson’s disease (PD).
May 15, 2024
·
4 min read
Job Trends
Employment and funding growth fell in 2025: California Life Sciences report
California life sciences jobs declined 1.8% last year, according to the new California Life Sciences sector report. While National Institutes of Health funding and venture capital investment rose, their growth slowed from the previous year.
May 15, 2026
·
2 min read
·
Angela Gabriel
Press Releases
CIRM Awards AcuraStem $7.5 Million in Grant Funding to Advance AS-241 Toward a First-in-Human Trial for ALS and FTD
April 29, 2026
·
3 min read
Press Releases
UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
May 27, 2026
·
9 min read
Press Releases
Senti Bio Receives Additional $1.0 Million Tranche from California Institute for Regenerative Medicines (CIRM) Grant for Advancing Clinical Development of SENTI-202
May 22, 2025
·
7 min read
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
Senti Biosciences, Inc., a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, announced that the California Institute for Regenerative Medicines has awarded an $8 million grant to Senti Bio.
July 1, 2024
·
9 min read
1 of 66,872
Next
